- Potential cure for sickle cell disease raises few concerns for FDA panel CBS News
- CRISPR Therapeutics Announces Completion of FDA Advisory Committee Meeting for Exagamglogene Autotemcel (exa-cel) for Severe Sickle Cell Disease GlobeNewswire
- FDA moves closer to sickle cell cure that uses gene editing NBC News
- Vertex, Crispr Get FDA Panel Support for Sickle-Cell Treatment Bloomberg
- FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study Reuters.com
- View Full coverage on Google News